Pétra Eid
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pétra Eid has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Catherine Creuzot-Garcher
Université Bourgogne Europe Dijon France
5 shared publications - Louis Arnould
Ophthalmology Department, Dijon University Hospital, Dijon CEDEX, France
4 shared publications - Pierre-Henry Gabrielle
Department of Ophthalmology Dijon University Hospital Dijon France
4 shared publications - Alain Marie Bron
Rothschild Foundation Hospital, Paris, France
3 shared publications - Steinberg Laure-Anne
Department of Ophthalmology, Dijon University Hospital, 21079 Dijon CEDEX, France
3 shared publications - Atif Anwer
Artificial Vision and Imaging (ImViA), Imagerie Fonctionnelle et Moléculaire et Traitement des Images Médicales (IFTIM), (EA 7535), Faculty of Health Sciences, Université de Bourgogne Franche-Comté, 21078 Dijon, France
2 shared publications
Latest Publications
- Open Access
- 24 February 2026
- Published by Wiley in Clinical & Experimental Ophthalmology
- Vol. 54 (4) , 492-499
Prognostic Factors in Patients With Submacular Haemorrhage Complicating Age‐Related Macular Degeneration: A Post Hoc Analysis of the STAR Study
Background: To investigate prognostic factors of recent submacular haemorrhage (SMH) complicating neovascular age‐related macular degeneration (nAMD) treated with surgery or pneumatic displacement combined with intravitreal injection of anti‐vascular endothelial growth factor. Methods: Post hoc analysis of the STAR randomised controlled trial data evaluating the influence of baseline clinical and imaging characteristics on visual outcomes over 6 months using multivariate generalised additive mixed models. Results: Patients with worse baseline visual acuity (VA) had faster (estimated degree of freedom [EDF] = 2.87, p < 0.001) and greater predicted visual gain (difference = +21.03 [14.64; 27.42] letters for eyes with 10 vs. 40 letters at baseline, p < 0.001) and lower predicted VA at 6 months (difference = −8.82 [−15.14; −2.52] letters for eyes with 10 vs. 40 letters at baseline, p < 0.001), whereas patients with better baseline VA showed more stable trajectories of predicted visual gain and higher predicted VA at 6 months. Thinner SMH (≤ 1000 μm) was significantly associated with faster (EDF = 2.93 for ≤ 1000 μm vs. 2.66 for > 1000 μm) and greater predicted visual improvement (difference = +13.5 [3.66; 23.39] letters between ≤ 1000 and > 1000 μm, p < 0.001) and higher predicted final VA (difference = +13.00 [3.11; 22.80] letters between ≤ 1000 and > 1000 μm, p < 0.001). Interactions between the treatment group and both VA and SMH thickness were non‐significant. Conclusion: Better VA and lower SMH thickness at baseline were significantly associated with better visual outcomes over 6 months, independently of treatment arm in SMH complicating nAMD. Trial Registration: ClinicalTrials.gov identifier: NCT02557451
- 24 February 2026
- Published by Wiley in Clinical & Experimental Ophthalmology
- Vol. 54 (4) , 492-499
Open AccessPrognostic Factors in Patients With Submacular Haemorrhage Complicating Age‐Related Macular Degeneration: A Post Hoc Analysis of the STAR Study
Background: To investigate prognostic factors of recent submacular haemorrhage (SMH) complicating neovascular age‐related macular degeneration (nAMD) treated with surgery or pneumatic displacement combined with intravitreal injection of anti‐vascular endothelial growth factor. Methods: Post hoc analysis of the STAR randomised controlled trial data evaluating the influence of baseline clinical and imaging characteristics on visual outcomes over 6 months using multivariate generalised additive mixed models. Results: Patients with worse baseline visual acuity (VA) had faster (estimated degree of freedom [EDF] = 2.87, p < 0.001) and greater predicted visual gain (difference = +21.03 [14.64; 27.42] letters for eyes with 10 vs. 40 letters at baseline, p < 0.001) and lower predicted VA at 6 months (difference = −8.82 [−15.14; −2.52] letters for eyes with 10 vs. 40 letters at baseline, p < 0.001), whereas patients with better baseline VA showed more stable trajectories of predicted visual gain and higher predicted VA at 6 months. Thinner SMH (≤ 1000 μm) was significantly associated with faster (EDF = 2.93 for ≤ 1000 μm vs. 2.66 for > 1000 μm) and greater predicted visual improvement (difference = +13.5 [3.66; 23.39] letters between ≤ 1000 and > 1000 μm, p < 0.001) and higher predicted final VA (difference = +13.00 [3.11; 22.80] letters between ≤ 1000 and > 1000 μm, p < 0.001). Interactions between the treatment group and both VA and SMH thickness were non‐significant. Conclusion: Better VA and lower SMH thickness at baseline were significantly associated with better visual outcomes over 6 months, independently of treatment arm in SMH complicating nAMD. Trial Registration: ClinicalTrials.gov identifier: NCT02557451
- 21 October 2023
- Published by Elsevier in Journal Français d'Ophtalmologie
- Vol. 47 (2) , 103972
Imagerie « ultra-grand champ » d’un fundus albipunctatus découvert chez une patiente de 30 ans consultant pour héméralopie
- 21 October 2023
- Published by Elsevier in Journal Français d'Ophtalmologie
- Vol. 47 (2) , 103972
Imagerie « ultra-grand champ » d’un fundus albipunctatus découvert chez une patiente de 30 ans consultant pour héméralopie
- Open Access
A Retinal Oct-Angiography and Cardiovascular STAtus (RASTA) Dataset of Swept-Source Microvascular Imaging for Cardiovascular Risk Assessment
In the context of exponential demographic growth, the imbalance between human resources and public health problems impels us to envision other solutions to the difficulties faced in the diagnosis, prevention, and large-scale management of the most common diseases. Cardiovascular diseases represent the leading cause of morbidity and mortality worldwide. A large-scale screening program would make it possible to promptly identify patients with high cardiovascular risk in order to manage them adequately. Optical coherence tomography angiography (OCT-A), as a window into the state of the cardiovascular system, is a rapid, reliable, and reproducible imaging examination that enables the prompt identification of at-risk patients through the use of automated classification models. One challenge that limits the development of computer-aided diagnostic programs is the small number of open-source OCT-A acquisitions available. To facilitate the development of such models, we have assembled a set of images of the retinal microvascular system from 499 patients. It consists of 814 angiocubes as well as 2005 en face images. Angiocubes were captured with a swept-source OCT-A device of patients with varying overall cardiovascular risk. To the best of our knowledge, our dataset, Retinal oct-Angiography and cardiovascular STAtus (RASTA), is the only publicly available dataset comprising such a variety of images from healthy and at-risk patients. This dataset will enable the development of generalizable models for screening cardiovascular diseases from OCT-A retinal images.
Open AccessA Retinal Oct-Angiography and Cardiovascular STAtus (RASTA) Dataset of Swept-Source Microvascular Imaging for Cardiovascular Risk Assessment
In the context of exponential demographic growth, the imbalance between human resources and public health problems impels us to envision other solutions to the difficulties faced in the diagnosis, prevention, and large-scale management of the most common diseases. Cardiovascular diseases represent the leading cause of morbidity and mortality worldwide. A large-scale screening program would make it possible to promptly identify patients with high cardiovascular risk in order to manage them adequately. Optical coherence tomography angiography (OCT-A), as a window into the state of the cardiovascular system, is a rapid, reliable, and reproducible imaging examination that enables the prompt identification of at-risk patients through the use of automated classification models. One challenge that limits the development of computer-aided diagnostic programs is the small number of open-source OCT-A acquisitions available. To facilitate the development of such models, we have assembled a set of images of the retinal microvascular system from 499 patients. It consists of 814 angiocubes as well as 2005 en face images. Angiocubes were captured with a swept-source OCT-A device of patients with varying overall cardiovascular risk. To the best of our knowledge, our dataset, Retinal oct-Angiography and cardiovascular STAtus (RASTA), is the only publicly available dataset comprising such a variety of images from healthy and at-risk patients. This dataset will enable the development of generalizable models for screening cardiovascular diseases from OCT-A retinal images.
- Open Access
- 5 June 2023
- Published by MDPI AG in Preprints.org
A Retinal Oct-Angiography and Cardiovascular STAtus (RASTA) Dataset on Swept-Source Microvascular Imaging for Cardiovascular Risk Assessment
In a context of exponential demographic growth, the imbalance between human resources and public health problems is impelling us to envision other solutions to the difficulties faced in the diagnosis, prevention and large-scale management of the most common diseases. Cardiovascular diseases represent the leading cause of morbidity and mortality worldwide. A large-scale screening program would make it possible to promptly identify patients with high cardiovascular risk in order to manage them adequately. Optical coherence tomography-angiography (OCT-A), as a window into the state of the cardiovascular system, is a rapid, reliable, and reproducible imaging examination that enables prompt identification of at-risk patients through the use of automated classification models. One challenge that limits the development of computer-aided diagnostic programs is the small number of open-source OCT-A acquisitions available. To facilitate the development of such models, we have assembled a set of images of the retinal microvascular system from 499 patients. It consists of 814 angiocubes as well as 2005 en face images. Angiocubes were captured with a swept-source OCT-A device of patients with varying overall cardiovascular risk. To the best of our knowledge, our dataset, RASTA, is the only publicly available dataset comprising such a variety of images from healthy and at-risk patients. This dataset will enable the development of generalizable models for screening of cardiovascular diseases from OCT-A retinal images.
- 5 June 2023
- Published by MDPI AG in Preprints.org
Open AccessA Retinal Oct-Angiography and Cardiovascular STAtus (RASTA) Dataset on Swept-Source Microvascular Imaging for Cardiovascular Risk Assessment
In a context of exponential demographic growth, the imbalance between human resources and public health problems is impelling us to envision other solutions to the difficulties faced in the diagnosis, prevention and large-scale management of the most common diseases. Cardiovascular diseases represent the leading cause of morbidity and mortality worldwide. A large-scale screening program would make it possible to promptly identify patients with high cardiovascular risk in order to manage them adequately. Optical coherence tomography-angiography (OCT-A), as a window into the state of the cardiovascular system, is a rapid, reliable, and reproducible imaging examination that enables prompt identification of at-risk patients through the use of automated classification models. One challenge that limits the development of computer-aided diagnostic programs is the small number of open-source OCT-A acquisitions available. To facilitate the development of such models, we have assembled a set of images of the retinal microvascular system from 499 patients. It consists of 814 angiocubes as well as 2005 en face images. Angiocubes were captured with a swept-source OCT-A device of patients with varying overall cardiovascular risk. To the best of our knowledge, our dataset, RASTA, is the only publicly available dataset comprising such a variety of images from healthy and at-risk patients. This dataset will enable the development of generalizable models for screening of cardiovascular diseases from OCT-A retinal images.
- Open Access
- 4 April 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (7) , 2687
Early Retinal Microvascular Changes Assessed with Swept-Source OCT Angiography in Type 1 Diabetes Patients without Retinopathy
Type 1 diabetes is a chronic disease that can lead to vision loss when diabetic retinopathy develops. Retinal microvascular alterations occur before the appearance of clinical signs on a fundus examination. This study aimed to analyze retinal vascular parameters on optical coherence tomography angiography (OCT-A) in patients with type 1 diabetes without diabetic retinopathy in comparison with non-diabetic volunteers. This cross-sectional study was conducted at Dijon University Hospital from 2018 to 2020. Vascular densities were measured using macular OCT-A. In total, 98 diabetes patients and 71 non-diabetic volunteers were enrolled. A statistically significant lower vascular density of the inner circle was found in the superficial capillary plexus (SCP) in the diabetes group (p < 0.01). There was a statistically significant correlation between central vascular density in the deep capillary plexus (DCP) and total daily insulin intake (p = 0.042); furthermore, use of the FreeStyle Libre (FSL) device was associated with higher vascular densities in both the SCP (p = 0.034 for outer circle density) and DCP (p < 0.01 for inner circle density and p = 0.023 for outer circle density). Retinal microvascularization was early-altered in type 1 diabetes, and using the FSL device seemed to preserve retinal microvascularization.
- 4 April 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (7) , 2687
Open AccessEarly Retinal Microvascular Changes Assessed with Swept-Source OCT Angiography in Type 1 Diabetes Patients without Retinopathy
Type 1 diabetes is a chronic disease that can lead to vision loss when diabetic retinopathy develops. Retinal microvascular alterations occur before the appearance of clinical signs on a fundus examination. This study aimed to analyze retinal vascular parameters on optical coherence tomography angiography (OCT-A) in patients with type 1 diabetes without diabetic retinopathy in comparison with non-diabetic volunteers. This cross-sectional study was conducted at Dijon University Hospital from 2018 to 2020. Vascular densities were measured using macular OCT-A. In total, 98 diabetes patients and 71 non-diabetic volunteers were enrolled. A statistically significant lower vascular density of the inner circle was found in the superficial capillary plexus (SCP) in the diabetes group (p < 0.01). There was a statistically significant correlation between central vascular density in the deep capillary plexus (DCP) and total daily insulin intake (p = 0.042); furthermore, use of the FreeStyle Libre (FSL) device was associated with higher vascular densities in both the SCP (p = 0.034 for outer circle density) and DCP (p < 0.01 for inner circle density and p = 0.023 for outer circle density). Retinal microvascularization was early-altered in type 1 diabetes, and using the FSL device seemed to preserve retinal microvascularization.
- Open Access
- 21 August 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (16) , 4914
Cystoid Macular Edema after Rhegmatogenous Retinal Detachment Repair with Pars Plana Vitrectomy: Rate, Risk Factors, and Outcomes
(1) Background: The aim was to describe the rate and outcomes of cystoid macular edema (CME) after pars plana vitrectomy (PPV) for primary rhegmatogenous retinal detachment (RRD) and to identify risk factors and imaging characteristics. (2) Methods: A retrospective consecutive case study was conducted over a 5-year period among adult patients who underwent PPV for primary RRD repair. The main outcome measure was the rate of CME at 12 months following PPV. (3) Results: Overall, 493 eyes were included. The CME rate was 28% (93 patients) at 12 months. In multivariate analysis, eyes with worse presenting visual acuity (VA) (odds ratio [OR], 1.55; 95% CI, 1.07–2.25; p = 0.02) and grade C proliferative vitreoretinopathy (PVR) (OR, 2.88; 95% CI, 1.04–8.16; p = 0.04) were more at risk of developing CME 1 year after PPV. Endolaser retinopexy was associated with a greater risk of CME than cryotherapy retinopexy (OR, 3.06; 95% CI, 1.33–7.84; p = 0.01). Eyes undergoing cataract surgery within 6 months of the initial RRD repair were more likely to develop CME at 12 months (OR, 1.96; 95% CI, 1.06–3.63; p = 0.03). (4) Conclusions: CME is a common complication after PPV for primary RRD repair. Eyes with worse presenting VA, severe PVR at initial presentation, endolaser retinopexy, and cataract surgery within 6 months of initial RRD repair were risk factors for postoperative CME at 12 months.
- 21 August 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (16) , 4914
Open AccessCystoid Macular Edema after Rhegmatogenous Retinal Detachment Repair with Pars Plana Vitrectomy: Rate, Risk Factors, and Outcomes
(1) Background: The aim was to describe the rate and outcomes of cystoid macular edema (CME) after pars plana vitrectomy (PPV) for primary rhegmatogenous retinal detachment (RRD) and to identify risk factors and imaging characteristics. (2) Methods: A retrospective consecutive case study was conducted over a 5-year period among adult patients who underwent PPV for primary RRD repair. The main outcome measure was the rate of CME at 12 months following PPV. (3) Results: Overall, 493 eyes were included. The CME rate was 28% (93 patients) at 12 months. In multivariate analysis, eyes with worse presenting visual acuity (VA) (odds ratio [OR], 1.55; 95% CI, 1.07–2.25; p = 0.02) and grade C proliferative vitreoretinopathy (PVR) (OR, 2.88; 95% CI, 1.04–8.16; p = 0.04) were more at risk of developing CME 1 year after PPV. Endolaser retinopexy was associated with a greater risk of CME than cryotherapy retinopexy (OR, 3.06; 95% CI, 1.33–7.84; p = 0.01). Eyes undergoing cataract surgery within 6 months of the initial RRD repair were more likely to develop CME at 12 months (OR, 1.96; 95% CI, 1.06–3.63; p = 0.03). (4) Conclusions: CME is a common complication after PPV for primary RRD repair. Eyes with worse presenting VA, severe PVR at initial presentation, endolaser retinopexy, and cataract surgery within 6 months of initial RRD repair were risk factors for postoperative CME at 12 months.